Injectable ketorolac tromethamine recalled nationwide for potential cross-contamination
Nephron Pharmaceuticals is recalling Ketorolac Tromethamine Injection due to manufacturing deviations that could lead to cross-contamination. The recall affects 5,040 vials distributed nationwide.
- Product
- KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
- Category
- Drug
- Distribution
- Distributed nationwide